Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals-Reference-Cited by-同舟云学术

Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals

Published:2016-01-21 Issue:7 Volume:12 Page:815-822
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Casanova Ramon¹,Varma Sudhir²,Simpson Brittany³⁴,Kim Min⁵,An Yang⁶,Saldana Santiago¹,Riveros Carlos⁷,Moscato Pablo⁷,Griswold Michael⁸,Sonntag Denise⁹,Wahrheit Judith⁹,Klavins Kristaps⁹,Jonsson Palmi V.¹⁰,Eiriksdottir Gudny¹¹,Aspelund Thor¹⁰¹¹,Launer Lenore J.¹²,Gudnason Vilmundur¹⁰¹¹,Legido Quigley Cristina⁵,Thambisetty Madhav³

Affiliation:

1. Department of Biostatistical Sciences Wake Forest School of Medicine Winston‐Salem NC USA

2. HiThru Analytics LLC Laurel MD USA

3. Clinical and Translational Neuroscience Unit, Laboratory of Behavioral Neuroscience National Institute on Aging, National Institutes of Health Baltimore MD USA

4. School of Medicine University of Mississippi Medical Center Jackson MS USA

5. Institute of Pharmaceutical Science King's College London UK

6. Laboratory of Behavioral Neuroscience National Institute on Aging, National Institutes of Health Baltimore MD USA

7. School of Electrical Engineering and Computer Science University of Newcastle Callaghan Australia

8. Center of Biostatistics and Bioinformatics University of Mississippi Medical Center Jackson MS USA

9. BIOCRATES Life Sciences AG Innsbruck Austria

10. Faculty of Medicine University of Iceland Reykjavik Iceland

11. Icelandic Heart Association Kopavogur Iceland

12. Laboratory of Epidemiology, Demography and Biometry National Institute on Aging Bethesda MD USA

Funder

National Institute on Aging

National Institutes of Health

Hjartavernd

National Institute on Aging Intramural Research Program

Icelandic Heart Association

Icelandic Parliament

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Clinical Neurology,Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2015.12.008

Reference27 articles.

1. The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

2. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

3. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

4. Recent advances in the application of metabolomics to Alzheimer's Disease

5. Toward Metabolomic Signatures of Cardiovascular Disease

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mendelian Randomization of Blood Metabolites Suggests Circulating Glutamine Protects Against Late-Onset Alzheimer’s Disease;Journal of Alzheimer's Disease;2024-04-02

2. Therapeutic potential of Thai herbal formula for cognitive impairment: A metabolomics approach for Comprehensive Insights;Heliyon;2024-04

3. Integrative Multimodal Metabolomics to Early Predict Cognitive Decline Among Amyloid Positive Community-Dwelling Older Adults;The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences;2024-03-07

4. Untargeted metabolomic profiling identifies Alzheimer’s disease-specific signatures in serum and faeces impacted by tetrahydroxy stilbene glycoside through UPLC-Q-TOF/MS;Pharmacological Research - Modern Chinese Medicine;2024-03

5. Plasma metabolic profiles predict future dementia and dementia subtypes: a prospective analysis of 274,160 participants;Alzheimer's Research & Therapy;2024-01-22